A real-world study on SGLT2 inhibitors and diabetic kidney disease progression
A real-world study on SGLT2 inhibitors and diabetic kidney disease progression is a paper indexed in ScholarIQ from OpenAlex.
How many citations does A real-world study on SGLT2 inhibitors and diabetic kidney disease progression have?
A real-world study on SGLT2 inhibitors and diabetic kidney disease progression has 35 citations in the OpenAlex counts ScholarIQ stores.
When was A real-world study on SGLT2 inhibitors and diabetic kidney disease progression published?
A real-world study on SGLT2 inhibitors and diabetic kidney disease progression has 2022 year in the ScholarIQ index.
What is the open-access status of A real-world study on SGLT2 inhibitors and diabetic kidney disease progression?
A real-world study on SGLT2 inhibitors and diabetic kidney disease progression has gold oa status in the ScholarIQ index.
What is the DOI of A real-world study on SGLT2 inhibitors and diabetic kidney disease progression?
The DOI for A real-world study on SGLT2 inhibitors and diabetic kidney disease progression is on the source record.
What is the PMID of A real-world study on SGLT2 inhibitors and diabetic kidney disease progression?
The PMID for A real-world study on SGLT2 inhibitors and diabetic kidney disease progression is on the source record.
What is the OpenAlex record for A real-world study on SGLT2 inhibitors and diabetic kidney disease progression?
The OpenAlex for A real-world study on SGLT2 inhibitors and diabetic kidney disease progression is on the source record.